It's always an honor to go to University of Toledo's Pharmaceutical Science research lab and see first hand what they are working on and the progression of their studies. On July 3, 2019, Dr. Angelique treated me lunch on campus the day before she was about to leave UT for Boston where she will continue her career in pharmaceutical research and wishes to continue her research in Triple Negative Breast Cancer. Saloni of UT will continue researching drug resistance in Triple Negative Breast Cancer in Dr. Amit Tiwari's lab.
 |
| Melissa and Dr. Angelique in her research office |
 |
| Triple Negative Breast Cancer cells under the microscope |
 |
| Saloni viewing results of her study on Triple Negative Breast Cancer cells |
 |
| Untreated Triple Negative Breast Cancer Cells |
 |
| Triple Negative Breast Cancer cells after being treated with an experimental drug, destroying the cancer cells. |